Cytomegalovirus (CMV) & HIV/AIDS: Research
- CMV Vector Vaccination Leads to Apparent Clearance of SIV Infection (March 25, 2013)
Selected research highlight from CROI 2013.
In Michael Palm HIV Basic Science, Vaccines & Prevention Project Weblog, from Treatment Action Group
On TheBodyPRO.com
- Does CMV Underlie the Increased Risk of Cardiovascular Disease in Patients With HIV? (April 16, 2012)
From aidsmap.com
- Experimental Vaccine Shows Promise in Preventing Cytomegalovirus Infection (March 19, 2009)
From U.S. National Institute of Allergy and Infectious Diseases
On TheBodyPRO.com
- Cytomegalovirus Retinitis: The Neglected Disease of the AIDS Pandemic (December 1, 2007)
In PLoS Medicine
- Cytomegalovirus Viremia, Mortality, and End-Organ Disease Among Patients With AIDS Receiving Potent Antiretroviral Therapies (April 15, 2005)
In Journal of Acquired Immune Deficiency Syndromes
- CMV Levels May Predict HIV Disease Progression (October 2004)
Quick recap of a study in The Lancet.
In HIV Treatment ALERTS!, from The Center for AIDS
- CMV-Related Disease: The Pros and Cons of HAART (October 2003)
In HIV Treatment ALERTS!, from The Center for AIDS
- HAART Good for Vision and Quality of Life, Studies Find (June 18, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
- A Synergistic Effect of HIV and CMV Infection/Reactivation on Response to HAART and Plasma CD8+/CD38+ But Not CD4+ Cell Populations in Patients With Primary HIV Infection (July 10, 2002)
In The XIV International AIDS Conference, from TheBodyPRO.com
- Oral Valganciclovir as Effective as IV Ganciclovir in Treating CMV Retinitis in AIDS Patients (April 12, 2002)
Results of a recent Emory University study.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
VIEW ALL ARTICLES
|
Advertisement
|